With Shares Down 41% This Year, Could Buying SoundHound AI (SOUN) Stock Today Set You Up for Life?
Key PointsSoundHound has been growing its revenue robustly.
Nasdaq News
ASML vs. Taiwan Semiconductor Manufacturing Company: What Revenue Trends Tell Investors About These Companies Tied to Artificial Intelligence
Key PointsTaiwan Semiconductor Manufacturing Company (TSMC) consistently generates higher absolute revenue totals than ASML during every quarterly reporting period tracked over the past two calendar years.
This Nearly 16%-Yielding Dividend Stock Has Paid Out $16 Billion Since 2008. Here's Why I'm Not Worried About the Next Payment.
Key PointsAGNC Investment has maintained its current monthly dividend rate since resetting it in 2020.
Adamas Trust, Inc. - Preferred Stock Price Target Increased by 11.88% to $21.52
The average one-year price target for Adamas Trust, Inc. - Preferred Stock (NASDAQGS:ADAMZ) has been revised to $21.52 / share. This is an increase of 11.88% from the prior estimate of $19.23 dated September 13, 2026. These figures represent aggregate analyst ta
3 Reasons to Claim Social Security at 62
Key PointsClaiming at 62 allows you to begin living off the benefits.
Adamas Trust, Inc. - Preferred Stock Price Target Increased by 16.27% to $31.60
The average one-year price target for Adamas Trust, Inc. - Preferred Stock (NASDAQGS:ADAML) has been revised to $31.60 / share. This is an increase of 16.27% from the prior estimate of $27.18 dated September 13, 2026. These figures represent aggregate analyst ta
Micron Just Extended Its Forecast for the AI Build-Out to 2031. Its Stock Is Bound to Defy History.
Key PointsMicron expects memory supply in 2027 and 2028 to be tighter than it was in 2026.
If a Recession Is Coming, This Is the 1 ETF I'd Buy Without a Second Thought
Key PointsThe Vanguard S&P 500 ETF won't shield you from losses, but it will help spread out your investments.
VIG vs. SCHD: The Better Dividend ETF Might Be the One With the Lower Yield
Key PointsThe Schwab U.S. Dividend Equity ETF (SCHD) targets high-quality, high-yield stocks but tilts more defensively.
Greg Abel Committed $6.8 Billion to Homebuilders Like Lennar, Increasing Berkshire's Stake by 30%, Even as Mortgage Rates Sit Near 7.5% and Builder Sentiment Hits Multi-Year Lows. Is This Bold Conviction or a Costly Miscalculation?
Key PointsWall Street tends to be myopically focused on near-term events.
Thinking About Buying 10-Year Treasury Notes Yielding 5.3% Instead of Dividend Stocks Like Coca-Cola? Consider These 3 Factors First.
Key PointsStocks that pay growing dividends yield progressively more over the lifetime of the investment.
If You've Saved This Much for Retirement by Age 60, You're Ahead of the Game
Key PointsThe median retirement savings for 60-year-olds is not as high as it should be.
Prediction: Berkshire Hathaway's 2026 Buybacks Will Top $10 Billion
Key PointsAfter no buybacks in 2025, Berkshire Hathaway put its stock repurchase plans back in action in 2026.
Where Will CoreWeave Stock Be in 5 Years?
Key PointsCoreWeave’s $104 billion revenue backlog shows strong demand for its AI computing capacity.
Stocks Settle Higher as Fed Rate Hike Concerns Ease
The S&P 500 Index ($SPX ) (SPY ) closed up by +0.73% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.00%. December E-mini S&P futures (ESZ26 ) rose +0.73%, and December E-mini...
How to Protect Your Portfolio as the Fed Raises Interest Rates
Key PointsA Federal Reserve tightening cycle was a catalyst for the last bear market.
FDA Approves Expanded Use Of Lilly's Jaypirca For CLL/SLL
(RTTNews) - Eli Lilly and Company (LLY) announced that the U.S. Food and Drug Administration approved an expanded indication for Jaypirca (pirtobrutinib) to treat adults with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have no k
Investing $500 Monthly Into This Growth ETF Could Be Your Ticket to $800,000
Key PointsThe Vanguard Morningstar Growth ETF (VUG) has averaged over 12% annually in total returns since its 2004 inception.
PennyMac Mortgage Investment Trust - Preferred Stock Price Target Increased by 17.60% to $37.17
The average one-year price target for PennyMac Mortgage Investment Trust - Preferred Stock (NYSE:PMTW) has been revised to $37.17 per share, as of October 1, 2026. This represents an increase of 17.60% from the prior estimate of $31.61 dated September 13, 2026. T
Here's the Max Social Security Benefit at Age 70 -- and How to Get It
Key PointsTo receive the maximum monthly benefit, you must wait until 70 to claim Social Security.
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed